RP
Rahul Patel
AyurBio Consulting, BioCryst, The University of Texas Southwestern Medical Center, Baylor College of Medicine, PRA Health Sciences
About
Rheumatologist (US ABIM Board Certified and trained), focused on drug development, supporting early to late stage studies, with experience in small molecule, biologics, and cell therapy/advanced therapeutic modalities.
Employment
-
AyurBio Consulting2024 - Present
-
BioCryst2020 - Present
-
PRA Health Sciences2016 - 2020
-
Sanofi-Aventis US LLC2013 - 2016
-
Parexel International Corp2011 - 2013
-
University of North Texas Health Science Center2004 - 2011
Education
-
The University of Texas Southwestern Medical Center fellowship training2001 - 2004
-
The University of Texas Southwestern Medical Center residency1998 - 2001
-
Baylor College of Medicine MD1994 - 1998
Projects & Funding
Projects & funding information is unavailable.
Publications (6)
- Axial spondyloarthritis: Moving beyond cytokine based therapies to cellular targets and advanced therapeutics Save
- Correspondence to: ‘CD19-CAR T-cell therapy induces deep tissue depletion of B cells’ by Tur et al Save
- Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial. Save
- Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosus. Save
- PI3K/AKT/mTOR hypersignaling in autoimmune lymphoproliferative disease engendered by the epistatic interplay of Sle1b and FASlpr Save
- PI3K/AKT Signaling and Systemic Autoimmunity Save